A Study of the Impact of Magnesium Supplements on Asthma Control

Abstract

Background: In the recent studies, the relationship between the magnesium and asthma has been more considered; hence, the present research has aimed to study this issue.  Methodology: The study is a Randomized double blind placebo control trial, which has been conducted on the asthmatic patients who have been divided into two groups: group one consisting of those who have taken placebo and group two including those who have taken magnesium supplement. In the beginning and during the weeks 4, 8 and 12, FVC, FEV1, FEV1/FVC and ACT score have been measured.  Results: 40 patients have been studied in two equal groups. The improvement rate of FEV1/FVC has been gradually increased in group2 and was significantly higher than group1 in the week 12. It was also higher in week 4 but not significantly. Moreover, according to FVC ratio, in weeks 4 and 12, the cure rate of the group2 was not significantly higher; however, it was significantly higher in the 8th week. The ACT score of group2 has also significantly increased in comparison to it in 4 weeks before the beginning of the study.  Conclusion: It seems that the magnesium supplement is helpful in improving the clinical and spirometric measurements of asthmatic patients.